Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
暂无分享,去创建一个
H. Brewer | E. Schaefer | E J Schaefer | L. Zech | F. Lindgren | H B Brewer | E. Rubalcaba | L A Zech | E A Rubalcaba | F T Lindgren | D W Anderson | T B Bronzert | D. Anderson | T. B. Bronzert
[1] C. Packard,et al. Dynamic properties of human high density lipoprotein apoproteins. , 1978, Journal of lipid research.
[2] H. Brewer,et al. The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins. , 1978, Biochemical and biophysical research communications.
[3] H. Peeters. The Lipoprotein Molecule , 1978, NATO Advanced Study Institutes Series.
[4] A Kagan,et al. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.
[5] A. Nichols. Human serum lipoproteins and their interrelationships. , 1967, Advances in biological and medical physics.
[6] P. Alaupovic,et al. Determination of human apolipoprotein E by electroimmunoassay. , 1976, Biochimica et biophysica acta.
[7] G. Assmann,et al. Apoprotein A metabolism in Tangier disease. , 1978, Atherosclerosis.
[8] A Rescigno,et al. Estimation of average times of residence, recycle and interconversion of blood-borne compounds using tracer methods. , 1973, The Journal of clinical endocrinology and metabolism.
[9] D. Cogan,et al. Ocular manifestations of familial high-density lipoprotein deficiency (Tangier disease). , 1979, Archives of ophthalmology.
[10] H. Brewer,et al. Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Havel,et al. Apoprotein composition of very low density lipoproteins of human serum. , 1975, The Journal of clinical investigation.
[12] S B Hulley,et al. HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.
[13] K. Weber,et al. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.
[14] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[15] A. Gotto,et al. A study of the cystine-containing apolipoprotein of human plasma high density lipoproteins: characterization of cyanogen bromide and tryptic fragments. , 1972, Biochimica et biophysica acta.
[16] D. Fredrickson,et al. Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease. , 1978, Metabolism: clinical and experimental.
[17] A. Chalvardjian,et al. Determination of lipid phosphorus in the nanomolar range. , 1970, Analytical biochemistry.
[18] F. Lindgren,et al. High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. , 1978, Atherosclerosis.
[19] A. Gotto,et al. Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein. , 1972, The Journal of clinical investigation.
[20] S. Eisenberg,et al. Radioimmunoassay of human high density lipoprotein apo-protein A-1. , 1975, Biochimica et biophysica acta.
[21] H. Brewer,et al. Human chylomicron apolipoprotein metabolism. , 1978, Biochemical and biophysical research communications.
[22] A. Gotto,et al. The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). I. The amino acid sequence of cyanogen bromide fragment II. , 1975, The Journal of biological chemistry.
[23] T. Forte,et al. Particle distribution of human serum high density lipoproteins. , 1977, Biochimica et biophysica acta.
[24] D. Fredrickson,et al. Tangier disease (familial high density lipoprotein deficiency). Clinical and genetic features in two adults. , 1965, The American journal of medicine.
[25] R. Lees,et al. Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease. , 1978, The New England journal of medicine.
[26] P. Alaupovic,et al. Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. , 1976, Biochemistry.
[27] David Glick,et al. Methods of Biochemical Analysis , 1956 .
[28] H. Brewer,et al. The plasma lipoproteins. , 1977, Advances in protein chemistry.
[29] A. Mcfarlane,et al. Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.
[30] J. Patsch,et al. Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation. , 1974, European journal of biochemistry.
[31] G. Assmann,et al. Isolation and Characterization of an Abnormal High Density Lipoprotein in Tangier Disease , 1977 .
[32] G. Assmann. Familial Lipoprotein Deficiency , 1978 .
[33] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.
[34] L. Avioli,et al. Tangier Disease: Combined Clinical Staff Conference at the National Institutes of Health , 1961 .
[35] R. Levy,et al. Cutaneous cholesterol ester deposition in Tangier disease. , 1967, Archives of dermatology.
[36] J. Gofman,et al. Ultracentrifugal analysis of serum lipoproteins. , 1954, Methods of biochemical analysis.
[37] G. Assmann,et al. The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins. , 1977, The Journal of clinical investigation.
[38] V. Ferrans,et al. The pathology of Tangier disease. A light and electron microscopic study. , 1975, The American journal of pathology.
[39] S. Olofsson,et al. Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. , 1978, Biochemistry.
[40] A. K. Solomon,et al. Advances in Biological and Medical Physics , 1949 .
[41] P. Alaupovic,et al. Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. , 1976, Clinical chemistry.
[42] M Berman,et al. Kinetic analysis of turnover data. , 1979, Progress in biochemical pharmacology.